These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 23673275

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neural correlates of impaired performance on the clock drawing test in Alzheimer's disease.
    Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M.
    Dement Geriatr Cogn Disord; 2005 Nov; 19(5-6):390-6. PubMed ID: 15802915
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI.
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [Abstract] [Full Text] [Related]

  • 31. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [Abstract] [Full Text] [Related]

  • 32. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease.
    Ober BA, Jagust WJ, Koss E, Delis DC, Friedland RP.
    J Clin Exp Neuropsychol; 1991 Sep; 13(5):752-72. PubMed ID: 1955530
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS, Alzheimer's Disease Neuroimaging Initiative.
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [Abstract] [Full Text] [Related]

  • 35. Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease.
    Cahn-Weiner DA, Sullivan EV, Shear PK, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
    J Int Neuropsychol Soc; 1999 Sep; 5(6):502-9. PubMed ID: 10561930
    [Abstract] [Full Text] [Related]

  • 36. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
    Teipel SJ, Willoch F, Ishii K, Bürger K, Drzezga A, Engel R, Bartenstein P, Möller HJ, Schwaiger M, Hampel H.
    Neurobiol Aging; 2006 May; 27(5):681-90. PubMed ID: 15908048
    [Abstract] [Full Text] [Related]

  • 37. Cerebral metabolism, cognition, and functional abilities in Alzheimer disease.
    Melrose RJ, Ettenhofer ML, Harwood D, Achamallah N, Campa O, Mandelkern M, Sultzer DL.
    J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):127-34. PubMed ID: 21856969
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.